Benjamin Lemasson1,
Stefanie Galbn2, Christina Tsien2, Charles R. Meyer1,3,
Timothy D. Johnson4, Thomas Leonard Chenevert1, Alnawaz
Rehemtulla1,2, Brian Dale Ross1, Craig J. Galbn1
1Radiology,
University of Michigan, Ann Arbor, MI, USA; 2Radiation Oncology,
University of Michigan, Center for Molecular Imaging, Ann Arbor, MI, USA; 3Biomedical,
University of Michigan, Center for Molecular Imaging, Ann Arbor, MI, USA; 4Biostatistics,
University of Michigan, Ann Arbor, MI, USA
We tested the hypothesis that the method used to analyze the physiological parameter can improve the parameters predictive value. As such we compaired the parametric response (PRM) map to several common methods for assessing response. In addition, we evaluated the impact of the volume of interest (VOI) and the time the mid-treatment rCBV map was acquired on the predictive value of one-year and overall survival in a cohort of glioma patients. Only PRM was predictive of response. In addition, PRM is shown to be robust with negligible sensitivity to the VOI or the time the mid-treatment rCBV map was acquired.